Mr. Prabhat Kumar

Mr. Prabhat Kumar
(Head -Pharma Quality,  at a Leading Global Service Provider)

In the current context of COVID, entire humanity are eagerly waiting for the outcome of “clinical trial”. This year 20 May2020 does have a special significance to raising awareness of the importance of clinical trials. International Clinical Trials Day is just one way to bring more attention to clinical trials. Over last three centuries many human health indicators had improved, one common indicator across all the continents is life expectancy, which might have not possible without clinical trials.

I feel prevailed to be associated with this Nobel profession towards tireless journey of improving and saving lives. I congratulate and thanks all the stake holders including scientists, doctors, pharmacist, regulatory authorities, pharma companies and ethics committee for their contribution to bring new therapy to save human life.

 

More about Mr. Prabhat Kumar

Mr. Prabhat Kumar, has closely two decades of experience in quality functions of drug
development life cycle at pharmaceutical and CROs industries. He has a broad base of
experience in FDA, MHRA, EMA, PMDA, NMPA inspections hosting, range of various
GxP auditing and risk management across Asia pacific, middle east and Europe. Prabhat
Kumar is currently lead a Global Quality function group at Accenture and overall
responsible for QA and quality management functions of Life science. He actively
participated and represented as a speaker, panelist, program committee in various
industries and professional forum like DIA, SQA, CDSA, SCDM, Oxford university global
health network etc. Have done his post-graduation in life science from Goa university
and executive management program from Indian School of Business (ISB), Hyderabad.